| Date / Month / Year| | News | |
|---|---|---|
| 23 Aug 2024| | Notification of Warehouse and Office Building Sale Agreement | |
| 09 Aug 2024| | Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024 | |
| 09 Aug 2024| | Financial Statement Quarter 2/2024 (Reviewed) | |
| 09 Aug 2024| | Financial Performance Quarter 2 (F45) (Reviewed) | |
| 14 May 2024| | Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024 | |
| 14 May 2024| | Financial Performance Quarter 1 (F45) (Reviewed) | |
| 14 May 2024| | Financial Statement Quarter 1/2024 (Reviewed) | |
| 11 Apr 2024| | Notification of submission of Minutes of Annual General Meeting of shareholders No.30/2024. | |
| 29 Mar 2024| | The resolutions of the Annual General Meeting of Shareholders No.30/2024 | |
| 01 Mar 2024| | Publication of the invitation letter for the Annual General Meeting of shareholders No.30/2024 | |
| 19 Feb 2024| | Extension of allotment remaining ordinary shares under the General Mandate, Extension of issuance and offering of debentures, Suspension of the second dividend payment and the Record Date and AGM of Shareholders No.30/2024 (Revised1) | |
| 16 Feb 2024| | Financial Performance Yearly (F45) (Audited) | |
| 16 Feb 2024| | Extension of allotment remaining ordinary shares under the General Mandate, Extension of issuance and offering of debentures, Suspension of the second dividend payment and the Record Date and Annual General Meetings of Shareholders No.30/2024 | |
| 16 Feb 2024| | Management Discussion and Analysis Yearly Ending 31 Dec 2023 | |
| 16 Feb 2024| | Financial Statement Yearly 2023 (Audited) | |
| 23 Jan 2024| | Report on the result of the proposed agenda of the 2024 Annual General Meeting of shareholders, questions, and the director nomination. | |
| 23 Nov 2023| | Annual Holidays for 2024 | |
| 22 Nov 2023| | Invitation shareholders to propose Agenda of the 2024 AGM of shareholders, questions, and nominate persons | |
| 13 Nov 2023| | Date and time opportunity day Quarter 3/2023 | |
| 10 Nov 2023| | Management Discussion and Analysis Quarter 3 Ending 30 Sep 2023 |